SCHEMBL7089949

SCHEMBL7089949

CN1CCN(c2cccc(NS(=O)(=O)c3ccc4ccccc4c3)c2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 10/20 1.00
HTR6 P50406 8/20 1.00
HTR2A P28223 7/20 1.00
DRD3 P35462 7/20 1.00
HTR7 P34969 7/20 1.00
HTR1A P08908 6/20 1.00
GHSR Q92847 1/20 0.67
RAD52 P43351 1/20 0.67
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
ALDH1A1 P00352 1/20 0.59
MAPT P10636 1/20 0.59
HTR3A P46098 1/20 0.55
PHGDH O43175 1/20 0.54
PKM P14618 1/20 0.53
PKLR P30613 1/20 0.53
ATM Q13315 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27496150 0.83 HTR1A (0.71) HTR2CHTR6HTR2ADRD3HTR7
SCHEMBL27513811 0.82 HTR6 (0.69) HTR2CHTR6HTR2ADRD3HTR7
SCHEMBL27513105 0.81 HTR6 (0.68) HTR2CHTR6HTR2ADRD3HTR7
SCHEMBL4800759 0.81 GHSR (1.00) HTR2CHTR6HTR2ADRD3HTR7
SCHEMBL4800765 0.81 GHSR (1.00) HTR2CHTR6HTR2ADRD3HTR7
SCHEMBL7084057 0.81 HTR6 (0.67) HTR2CHTR6HTR2ADRD3HTR7
SCHEMBL7201600 0.81 RAD52 (0.73) HTR2CHTR6HTR2ADRD3HTR7
SCHEMBL6975625 0.79 HTR6 (0.78) HTR2CHTR6HTR2ADRD3HTR7
SCHEMBL18230177 0.78 HTR7 (0.63) HTR2CHTR6HTR2ADRD3HTR7
SCHEMBL13757739 0.75 DRD3 (0.60) HTR2CHTR6HTR2ADRD3HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946539-B1 SULPHONAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS SMITHKLINE BEECHAM PLC (GB) 2003-08-13 EP claimed
US-6599904-B2 5-HT6 receptor antagonists are believed to be of potential use in the treatment of certain CNS disorders; cognitive memory enhancement SMITHKLINE BEECHAM P.L.C. (GB) 2003-07-29 US disclosed